Two IP Partners Join King & Spalding
07/10/18
Two IP Partners Join King & Spalding
Summary: Two Harvard law school alums have joined King & Spalding as partners in their Trial and Global Disputes practice group in New York.
King & Spalding announced today the addition of two intellectual property lawyers to their Trial and Global Disputes practice group in the firm's New York office. Gerald Flattman and Evan Diamond joined the firm as partners. Flattman will serve as Global Chair of Life Sciences Patent Litigation group. The firm has made significant growth in the past month.
Trial and Global Disputes practice group head Andy Bayman said, “Gerald and Evan are first-chair patent trial lawyers who have been involved in a number of significant Hatch-Waxman disputes. Their capabilities in the pharma space dovetail well with the firm’s focus on clients in the Life Sciences sector and they add to the firm’s deep trial bench.”
The leader of the intellectual property team Kenny Steinthal added, “Gerald and Evan have substantial experience litigating high-stakes patent disputes in federal district courts and before the Patent Trial and Appeal Board of the U.S. Patent Office. Bringing them on board enhances our ability to be a firm of choice for companies protecting high-stakes branded products.”
Flattman has experience in patent litigation, licensing and counseling. He earned his J.D. from Harvard Law School and his B.S. from Yale University. He said of the move, “King & Spalding has a renowned reputation in the pharmaceutical, medical devices and life sciences sectors. We look forward to working with our new colleagues across their global network to help clients develop strong patent strategies so they can navigate the challenges and complexities that arise from litigation.”
Diamond earned his B.A. and M.S. from the University of Pennsylvania and his J.D. from Harvard Law School. He focuses on patent litigation matters, specifically on the fields of biotechnology and pharmaceuticals.
Photo: kslaw.com
Two IP Partners Join King & Spalding
Summary: Two Harvard law school alums have joined King & Spalding as partners in their Trial and Global Disputes practice group in New York.
King & Spalding announced today the addition of two intellectual property lawyers to their Trial and Global Disputes practice group in the firm's New York office. Gerald Flattman and Evan Diamond joined the firm as partners. Flattman will serve as Global Chair of Life Sciences Patent Litigation group. The firm has made significant growth in the past month.
Trial and Global Disputes practice group head Andy Bayman said, “Gerald and Evan are first-chair patent trial lawyers who have been involved in a number of significant Hatch-Waxman disputes. Their capabilities in the pharma space dovetail well with the firm’s focus on clients in the Life Sciences sector and they add to the firm’s deep trial bench.”
The leader of the intellectual property team Kenny Steinthal added, “Gerald and Evan have substantial experience litigating high-stakes patent disputes in federal district courts and before the Patent Trial and Appeal Board of the U.S. Patent Office. Bringing them on board enhances our ability to be a firm of choice for companies protecting high-stakes branded products.”
Flattman has experience in patent litigation, licensing and counseling. He earned his J.D. from Harvard Law School and his B.S. from Yale University. He said of the move, “King & Spalding has a renowned reputation in the pharmaceutical, medical devices and life sciences sectors. We look forward to working with our new colleagues across their global network to help clients develop strong patent strategies so they can navigate the challenges and complexities that arise from litigation.”
Diamond earned his B.A. and M.S. from the University of Pennsylvania and his J.D. from Harvard Law School. He focuses on patent litigation matters, specifically on the fields of biotechnology and pharmaceuticals.
Photo: kslaw.com
